Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 55B pseudogene" is a genomic sequence related to the functional TMEM55B gene, but it is classified as a **pseudogene**: a non-coding DNA segment derived from an ancestral protein-coding gene rendered non-functional by disabling mutations, frameshifts, or lack of regulatory features. Pseudogenes are not transcribed or translated into functional protein under normal circumstances, and they generally do not have therapeutic relevance. In rare cases, some pseudogenes can play regulatory roles through post-transcriptional mechanisms, but there is no published evidence for such activity for this specific pseudogene[2][3][6]. **Note:** If you are seeking information related to the functional protein, consult entries for the active gene/protein, "transmembrane protein 55B" (TMEM55B; formerly also called PIP4P1), which is an enzyme involved in phosphoinositide metabolism and cholesterol regulation, and has distinct biological and therapeutic interest[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on transmembrane protein 55B pseudogene.